Abstract
3D printing technology has emerged as a key driver behind an ongoing paradigm shift in the production process of various industrial domains. The integration of 3D printing into tissue engineering, by utilizing life cells which are encapsulated in specific natural or synthetic biomaterials (e.g., hydrogels) as bioinks, is paving the way toward devising many innovating solutions for key biomedical and healthcare challenges and heralds' new frontiers in medicine, pharmaceutical, and food industries. Here, we present a synthesis of the available 3D bioprinting technology from what is found and what has been achieved in various applications and discussed the capabilities and limitations encountered in this technology.
Highlights
Additive manufacturing (AM), the process of joining materials to make objects from computer-aided design (CAD) model data, such as 3D printing, shows a high potential to radically disrupt the global consumer market and trigger a manufacturing revolution in a broad spectrum of applications in many industry sectors. 3D printing is mostly well-known for custom-fabricating of industrial prototypes and parts using standard fabrication materials such as plastics and metals
3D bioprinting technology has emerged from the existing 3D printing, by utilizing life cells and gels as printing materials to create ex vivo and in vitro tissue models, which heralds’ new frontiers in medicine
We briefly presented the current bioprinting techniques and other essential elements pertaining to the application of 3D bioprinting for generating 3D tissues/organ
Summary
Additive manufacturing (AM), the process of joining materials to make objects from computer-aided design (CAD) model data, such as 3D printing, shows a high potential to radically disrupt the global consumer market and trigger a manufacturing revolution in a broad spectrum of applications in many industry sectors. 3D printing is mostly well-known for custom-fabricating of industrial prototypes and parts using standard fabrication materials such as plastics and metals. In vivo-like in vitro models can be printed using human cells, and a living organ or a network of organs can be created and utilized for preclinical drug screening as an animal alternative Another exciting application is using the 3d printing technology and advanced food formulations to produce animal-free meat that mimics the appearance, texture, and taste of animal-based meat (Figure 1). The bioink is ejected through the nozzle in the form of a thin filament and deposited on the substrate based on a CAD design that determines the position and path of nozzle movement to form the tissue in the desired 3d shape This technique originated from conventional 3D printing and has been found to be the most suitable method for the creation of large-scale constructs, due to its structural integrity, becoming more amenable to scale-up for organ fabrication [12]. The relatively high extrusion pressure through the nozzle imposes high shear stress on the bioink components and may lead to loss of cellular viability and distortion of the tissue structure [16, 30]. (b) Inkjet 3D bioprinting: is a non-contact technique that uses thermal, piezoelectric, or electromagnetic forces to expel bioink droplets onto a substrate replicating the CAD-based
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
